Skip to main content
Top
Published in: Neurological Sciences 3/2021

01-03-2021 | Guillain-Barré Syndrome | Letter to the Editor

Optic neuritis associated with sunitinib

Authors: Seunghee Na, Taewon Kim

Published in: Neurological Sciences | Issue 3/2021

Login to get access

Excerpt

Sunitinib malate is a receptor tyrosine kinase inhibitor commonly used to control angiogenesis and proliferation in cancer. Fatigue, gastrointestinal symptoms, hypertension, and myelosuppression are common adverse effects of sunitinib and are usually manageable. Although adverse neurological effects associated with sunitinib are rare [1], serious and unexpectable adverse reactions can be seen with widespread use of targeted anticancer therapies. Herein, we describe a rare case of optic neuritis (ON) in a patient with metastatic renal cell carcinoma treated with sunitinib. …
Literature
2.
go back to reference Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. Jama 242(7):623–632CrossRef Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. Jama 242(7):623–632CrossRef
3.
go back to reference Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D'Amore PA (2008) VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205(2):491–501CrossRef Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D'Amore PA (2008) VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205(2):491–501CrossRef
4.
go back to reference Aparicio-Gallego G, Blanco M, Figueroa A, García-Campelo R, Valladares-Ayerbes M, Grande-Pulido E, Antón-Aparicio L (2011) New insights into molecular mechanisms of sunitinib-associated side effects. Mol Cancer Ther 10(12):2215–2223CrossRef Aparicio-Gallego G, Blanco M, Figueroa A, García-Campelo R, Valladares-Ayerbes M, Grande-Pulido E, Antón-Aparicio L (2011) New insights into molecular mechanisms of sunitinib-associated side effects. Mol Cancer Ther 10(12):2215–2223CrossRef
5.
go back to reference Kanaan Z, Kulairi Z, Titianu M, Saha S, Kumar S (2014) Guillain-Barré syndrome following treatment with sunitinib malate. Case Rep Oncol Med 2014:1–2 Kanaan Z, Kulairi Z, Titianu M, Saha S, Kumar S (2014) Guillain-Barré syndrome following treatment with sunitinib malate. Case Rep Oncol Med 2014:1–2
6.
go back to reference Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, Matsuo K, Arisato T, Osame M (1998) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow–Fukase (POEMS) syndrome. Muscle Nerve 21(11):1390–1397CrossRef Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, Matsuo K, Arisato T, Osame M (1998) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow–Fukase (POEMS) syndrome. Muscle Nerve 21(11):1390–1397CrossRef
7.
go back to reference Babu KG, Attili VSS, Bapsy P, Anupama G (2007) Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia. Int Ophthalmol 27(1):43–44CrossRef Babu KG, Attili VSS, Bapsy P, Anupama G (2007) Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia. Int Ophthalmol 27(1):43–44CrossRef
9.
go back to reference Monge KS, Gálvez-Ruiz A, Alvárez-Carrón A, Quijada C, Matheu A (2015) Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case. Saudi J Ophthalmol 29(3):227–231CrossRef Monge KS, Gálvez-Ruiz A, Alvárez-Carrón A, Quijada C, Matheu A (2015) Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case. Saudi J Ophthalmol 29(3):227–231CrossRef
Metadata
Title
Optic neuritis associated with sunitinib
Authors
Seunghee Na
Taewon Kim
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 3/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04713-x

Other articles of this Issue 3/2021

Neurological Sciences 3/2021 Go to the issue